admin 
Bucharest, Romania — Bona Artis CRO is pleased to announce its participation as a sponsor at the Bucharest International Clinical Trials Symposium, held at the Hotel Marshal Garden. The event served as a premier gathering for the clinical research ecosystem, providing a high-level platform for dialogue and the exchange of industry best practices.
The symposium brought together a diverse range of stakeholders, including pharmaceutical companies, CROs, investigators, study coordinators, and regulatory authorities. Central to the agenda were critical topics shaping the future of the industry:
- Regulatory Evolution: The ongoing implementation and challenges of the European clinical trials framework.
- Digital Transformation: Leveraging technology for operational optimization and data integrity.
- Strategic Synergy: The essential need for transparent collaboration between sponsors, research sites, and regulatory bodies.
A Bridge Between Romania and Moldova
Beyond technical discussions, the symposium highlighted the growing importance of regional synergy. For Bona Artis CRO, supporting this event reflects our strategic commitment to bridging the clinical research communities of Romania and Moldova. We believe that aligning standards and fostering continuous knowledge exchange between these two markets is key to building a robust, innovative, and competitive research landscape in the region.
Commitment to Excellence
“Our sponsorship of this symposium underscores our dedication to a professional environment defined by excellence, strict compliance, and trusted partnerships,” said the Bona Artis CRO leadership team. “Sustainable progress in our field is driven by collective expertise and a shared vision for the future of healthcare innovation.”
We extend our sincere appreciation to the organizers and all participants for delivering a well-structured and impactful event that significantly contributes to the growth of the regional clinical research community.
